Amlexanox
SIGMA/SML0517 - ≥98% (HPLC)
Synonym: 2-
CAS Number: 68302-57-8
Empirical Formula (Hill Notation): C16H14N2O4
Molecular Weight: 298.29
MDL Number: MFCD00864790
Linear Formula: C16H14N2O4
Product Type: Chemical
| assay | ≥98% (HPLC) |
| color | white to beige |
| form | powder |
| InChI | 1S/C16H14N2O4/c1-7(2)8-3- |
| InChI key | SGRYPYWGNKJSDL-UHFFFAOYSA |
| Quality Level | 100 ![]() |
| shipped in | wet ice |
| SMILES string | CC(C)c1ccc2Oc3nc(N)c(cc3C |
| solubility | DMSO: 10 mg/mL at warmed, clear |
| storage temp. | −20°C |
| Biochem/physiol Actions: | Amlexanox elevates the amount of nonsense-containing mRNAs in treated cells and helps to generate full-length proteins effectively. |
| Biochem/physiol Actions: | Amlexanox is an anti-allergy and anti-asthma drug that blocks histamine and leukotriene release from leukocytes and mast cells. Amlexanox has also been shown to inhibit cahaperone activity of Hsp90, and S100A13, which is involved in transport of proteins devoid of signal peptide sequences. |
| Biochem/physiol Actions: | Amlexanox is an anti-allergy, anti-ulcer drug; S100A13 inhibitor. |
| General description: | Amlexanox is an anti-allergic drug with anti-inflammatory properties. |
| Packaging: | 10, 50 mg in glass bottle |
| Symbol | GHS07 |
| Signal word | Warning |
| Hazard statements | H302 |
| Hazard Codes | Xn |
| Risk Statements | 22-43 |
| Safety Statements | 36/37 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥98% (HPLC) |
| Storage Temp. | −20°C |
| UNSPSC | 12352200 |


